TrialDrug safety2019

Long-Term Safety and Tolerability of OnabotulinumtoxinA Treatment in Patients with Chronic Migraine: Results of the COMPEL Study.

Paul K Winner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.